The largest database of trusted experimental protocols

Peg dithiol

Manufactured by Merck Group
Sourced in United States, Germany

PEG-dithiol is a bifunctional crosslinking agent that contains two sulfhydryl (thiol) groups connected by a polyethylene glycol (PEG) spacer. The thiol groups can be used to form covalent bonds with other molecules, enabling the PEG spacer to act as a linker between two different entities.

Automatically generated - may contain errors

8 protocols using peg dithiol

1

Peptide-Crosslinked Hydrogel Fabrication

Check if the same lab product or an alternative is used in the 5 most similar protocols
For peptide-crosslinked hydrogels, a 10 mM solution of a custom-made peptide (GCRD-LPRTG-DRCG, Thermo Fisher Scientific, Waltham, MA) was prepared in PBS degassed with argon for 3 h. The LPRTG motif is an uncommon sequence in mammalian proteins and is specifically recognized and cleaved by a bacterial enzyme, SortaseA [68] . For PEG-dithiol crosslinked hydrogels, a 10 mM solution of PEG-dithiol (Mn = 1,000, Sigma Aldrich) was prepared in PBS. Hydrogels for mechanical testing were prepared by dispensing 75 µL of a concentrated GelMAL solution (6.66 wt%) into a Teflon mold (10 mm diameter, 100 µL). Crosslinking was initiated by addition of 25 µL peptide or PEG-dithiol solution for a final concentration of 5 wt% GelMAL and 2.5 mM crosslinker. The filled molds were kept at RT (25 °C) for 20 min during the gelation process. For cytotoxicity and ROS assays, 5 wt% GelMAL hydrogels were prepared as above, with primary hematopoietic stem and progenitor cells (HSPCs) resuspended at a density of 10 5 cells/mL (cytotoxicity) or 5x10 5 cells/mL (ROS) in the GelMAL precursor solution prior to dispensing into a Teflon mold (5 mm diameter, 20 µL) and addition of peptide crosslinker.
+ Open protocol
+ Expand
2

3D PEG-Hydrogel Encapsulation of MCTS

Check if the same lab product or an alternative is used in the 5 most similar protocols
3D hydrogels were prepared with a 20 kDa 4-arm PEG-MALeimide (PEG-MAL, Jenkem Technology, Plano, TX) at 10 wt % solution with 2 mM of cell adhesion peptide RGD (see the Supporting Information) and cross-linked at a 1:1 ratio with 1 kDa linear PEG-dithiol (Sigma-Aldrich) in sterile 2 mM triethanolamine (pH 7.4). Briefly, the MCTS pellet obtained from each method was resuspended in the PEG-RGD solution, and casting of hydrogels was done by mixing PEG-RGD-MCTS with the cross-linker at a ratio of 10:1. One microliter of the cross-linking solution was placed on the bottom of the plate, and then 9 µL of PEG-RGD-MCTS solution was added with vigorous mixing. Volumes of the hydrogels were limited to 10 µL to avoid oxygen and nutrient diffusion limitations. Gelation proceeded for 5 min41 (link) at 37 °C to ensure complete polymerization before the addition of culture medium. MCTS from the three MCTS formation methods were transferred to 3D PEG-MAL hydrogels, by using similar seeding densities. PolyNIPAAM MCTS were encapsulated at a ratio of one 150 µL polyNIPAAM gel to nine 10 µL PEG-MAL hydrogels, microwell MCTS at a ratio of 4 cm2, 1 mL to nine 10 µL PEG-MAL hydrogels, and suspension MCTS at a ratio of 9 cm2, 3 mL to nine 10 µL PEG-MAL hydrogels. MCTS created via either polyNIPAAM, microwells or suspension were transferred with cut pipet tips to minimize shear stress.
+ Open protocol
+ Expand
3

Biomimetic Hydrogel Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hyaluronic acid (60,000 Da, Genzyme Corporation, Cambridge, MA). Adipic dihydrazide, NHS-acrylate, acryloyl chloride, triethylamine, N-boc-ethylenediamine, 4-(4,6-dimethoxy[1 (link),3 (link),5 (link)]triazin-2-yl)-4-methylmorpholinium chloride (DMTMM), vanillin, potassium carbonate, ethyl-4-bromobutyrate, dimethylformamide (DMF), nitric acid, ethanol, sulfuric acid, trifluoroacetic acid, methanol, and acetic acid were purchased from Fisher Scientific and used without purification. Picoline borane complex and PEG dithiol (MW 1000 Da) were purchased from Sigma Aldrich and used without purification. Ac-FKGGGERC-NH2 (K peptide), Ac-GCRDGPQGIWGQDRCG-NH2, NQEQVSPLRGDSPGNH2 (Q-RGD peptide), and FITC-labeled NQEQVSPLRGDSPG-NH2 were purchased from Genscript (Piscataway, NJ) and used without purification. 4-arm PEG-vinylsulfone (PEG-VS, MW 40kDa) and 4-arm PEG-maleimide (PEG-MAL, MW 20kDa) were purchased from JenKem Inc. and used without further purification.
+ Open protocol
+ Expand
4

Hydrogel Formation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hydrogel monomers, 4-arm PEG4norb, were purchased from JenKem Technology USA (Plano, TX, USA). The photoinitiator LAP was synthetized as described previously [52 ]. The fluorescent dye Alexa Fluor488 was obtained from Invitrogen (Waltham, MA, USA), and propidium iodide from Carl Roth GmbH (Karlsruhe, Germany). Trypsinized bovine collagen type I, PureCol, was obtained from Advanced BioMatrix (Carlsbad, CA, USA), and fibronectin from Corning GmbH (Wiesbaden, Germany). Purified water was filtered with MilliQ system, Merck Millipore, Burlington, MA, USA. TGFα, insulin and BPE (bovine pituitary extract) were supplied as parts of the DermaLife K LifeFactors kit from Lifeline Cell Technology (Frederick, MD, USA). Human recombinant EGF (E. coli-derived) was obtained from PromoCell (Heidelberg, Germany), and recombinant human TGFβ-1 (CHO-derived) was purchased from Peprotech (Hamburg, Germany). EGF receptor monoclonal antibody 225 was obtained from Life Technologies (Carlsbad, CA, USA). All other reagents; i.e., PEG-dithiol; FITC-dextran, 40 kDa; 10xDMEM; 7.5% NaHCO3; fluorescein diacetate; mitomycin C; and EGFR inhibitor AG-1478, were obtained from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
5

Synthesis of Functionalized Polymeric Materials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Toluene extra dry, 3-(trimethoxysilyl)propyl methacrylate, acrylamide, ammonium persulfate, NN′-methylbis(acrylamide), NNN′N′-tetramethylethylene diamine, hexamethyldisilazane, sylgard 184 PDMS, alyl bromide and PEG di thiol were all purchased from Sigma Aldrich. Aqualon sodium CMC was purchased from Ashland Chemicals.
+ Open protocol
+ Expand
6

Hydrogel Biomaterial Components for Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hyaluronan (sHA, MW 10 kDa) was purchased from LifeCore Biomedical (United States). Dermatan sulfate (DS, MW 30 kDa) was purchased from Merck (Germany). Chondroitin sulfate A (CS, MW 10–30 kDa) and heparin (Hep, MW 16.5 kDa) were obtained from Biosynth-Carbosynth (United Kingdom). PEG-dithiol (MW 1 kDa), methylcellulose (4,000 cP) and OptiPrep (density gradient medium) were purchased from Sigma-Aldrich (Germany). The linRGD peptide (sequence: GCGWGRGDSPG) was purchased from PSL GmbH (Germany), the crosslinker peptide (sequence: GCREGPQGIWGQERCG) from Pepscan (Netherlands). 8-arm PEG with terminal vinyl sulfone groups (PEG-VS, MW 20 kDa, tripentaerythritol core) was obtained from JenKem Technology (United States). Recombinant human VEGF was purchased from R&D Systems (United States). Human umbilical vein endothelial cells (HUVECs, pooled donor, cryopreserved), endothelial cell growth medium (ECGM) and basal medium were purchased from Promocell (Germany).
+ Open protocol
+ Expand
7

Peptide-Crosslinked Hydrogel Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
For peptide-crosslinked hydrogels, a 10 mM solution of a custom-made peptide (GCRD-LPRTG-DRCG, Thermo Fisher Scientific, Waltham, MA) was prepared in PBS degassed with argon for 3 h. The LPRTG motif is an uncommon sequence in mammalian proteins and is specifically recognized and cleaved by a bacterial enzyme, SortaseA [65 (link)]. For PEG-dithiol crosslinked hydrogels, a 10 mM solution of PEG-dithiol (Mn = 1,000, Sigma Aldrich) was prepared in PBS. Hydrogels for mechanical testing were prepared by dispensing 75 μL of a concentrated GelMAL solution (6.66 wt%) into a Teflon mold (10 mm diameter, 100 μL). Crosslinking was initiated by addition of 25 μL peptide or PEG-dithiol solution for a final concentration of 5 wt% GelMAL and 2.5 mM crosslinker. The filled molds were kept at RT (25 °C) for 20 min during the gelation process. For cytotoxicity and ROS assays, 5 wt% GelMAL hydrogels were prepared as above, with primary hematopoietic stem and progenitor cells (HSPCs) resuspended at a density of 105 cells/mL (cytotoxicity) or 5×105 cells/mL (ROS) in the GelMAL precursor solution prior to dispensing into a Teflon mold (5 mm diameter, 20 μL) and addition of peptide crosslinker (Figure 2).
+ Open protocol
+ Expand
8

PEG-based Hydrogel Encapsulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pre-polymer solution is prepared in PBS containing 2-3 mM 20 kDa 4-armed PEG-norbornene (PEG-NB, JenKem Technology), an off-stoichiometric amount of dithiol-containing, MMP-degradable cross-linking peptide (KCGPQGIWGQCK, Iris Biotech), 1 mM CRGDS-peptide (Iris Biotech) and 3 mM of the photo-initiator lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP, synthesized as previously described 35, 60 ). To decrease the degradability of the network, parts of the peptide cross-linker are substituted by a 1 kDa PEG chain that contains a thiol group at each end (PEG-dithiol, Sigma). To encapsulate cells in the gel, HT-1080 cells, suspended in PBS, are added to the pre-polymer solution at a final concentration of 6.7 Â 10 5 cells per ml.
To tune the gel composition, we can vary the amount of PEG-NB monomer, as well as the amount of cross-linker. The cross-linker ratio r c is defined according to eqn (3), by comparing the ratio of functional groups of the cross-linker (two thiol groups in each cross-linker) to the concentration of functional groups of the PEG-NB monomer (4 norbornene groups on each monomer) in the pre-polymer solution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!